CLIN.L Share News (CLIN)
CLIN Share
CLIN Share
CLIN Share
CLIN Share
CLIN
CLIN Share
CLIN Broker
CLIN Directors
CLIN Financial
CLIN
CLIN Short
CLIN
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - WINNERS----------Smurfit
Read more
(Sharecast News) - Clinigen Group shares jumped on Wednesday after the company signed an agreement with Novartis to acquire the US rights to its Proleukin drug for up to $210m in cash.
Read moreLONDON (Alliance News) - Pharmaceuticals firm Clinigen Group PLC's shares rose early Wednesday as it announced the purchase of the rights to one of Novartis International AG's were up 12%
Read moreLONDON (Alliance News) - Clinigen Group PLC on Tuesday said it appointed Nick Keher as group chief financial officer with effect from March 19.Keher replaces current CFO Martin Abell, who a
Read more(Sharecast News) - AIM-listed pharmaceutical and services company Clinigen Group has appointed Nick Keher as its new chief financial officer with effect from 19 March.
Read moreLONDON (Alliance News) - Clinigen Group PLC on Tuesday expressed confidence in delivering progress in its full financial year after it saw a strong earnings growth in the first half.The for
Read more(Sharecast News) - Clinigen Group on Tuesday reported that, following a series of acquisitions, it expects to report a sharp rise in revenue and profit when it publishes its half-year results next month.
Read moreFriday 2 NovemberMurgitroyd GroupMonday 5 NovemberRandgold Resources (re Barrick Gold
Read moreLONDON (Alliance News) - Clinigen Group PLC on Thursday said it placed 9.5 million shares at a price of 845 pence each, raising GBP80 million.The stock closed 11% lower on Thursday at per a
Read more(Sharecast News) - Thomas Cook Group: UBS upgrades to neutral with a target price of 60p.
Read moreLONDON (Alliance News) - Clinigen Group PLC on Thursday announced a share placing to help pay for the acquisition of packaging and distribution services company CSM Parent Inc for up to USD240 in
Read more(Sharecast News) - Clinigen plans to raise £80m from investors to fund two new acquisitions following a "strong performance" from one of its previous additions in its last trading year.
Read moreFriday 21 September Smiths GroupFull Year ResultsSIGHalf Year SaatchiHalf Year +
Read more(Sharecast News) - Pharmaceutical and services company Clinigen has acquired the global rights to severe malignant osteoperosis treatment Imukin from Horizon Pharma for an undisclosed sum.
Read moreLONDON (Alliance News) - Clinigen Group PLC said Wednesday that it acquired the global rights to osteoporosis drug Imukin from Horizon Pharma PLC.The FTSE 250 pharmaceutical company said it
Read more